Endoscopic retrograde cholangiopancreatography (ERCP) has a significant complication rate which can be lowered by adopting technical variations of proven beneficial effect and prophylactic maneuvers such as pancreatic stenting during ERCP or periprocedural non-steroidal anti-inflammatory drug administration. However, adoption of these prophylactic maneuvers by endoscopists is not uniform. In this editorial we discuss the beneficial effects of the aforementioned maneuvers.
Keywords: Acute necrotizing; Anti-inflammatory Agents; Catheterization; Cholangiopancreatography; Complications; Endoscopic retrograde; Non-steroidal; Pancreatitis; Stents.